Brief: Senores Pharmaceuticals Acquires 14 ANDAs From Dr. Reddy's Laboratories
04/03/2025 10:36
March 4 (Reuters) - Senores Pharmaceuticals Ltd SENO.NS: ACQUIRES 14 ANDAS FROM DR. REDDY'S LABORATORIES ACQUISITION INCLUDES 13 APPROVED ANDAS AND 1 PENDING APPROVAL ADDRESSABLE OPPORTUNITY OF ACQUIRED ANDAS IN USA APPROX. $421 MILLION Source text: ID:nBSEcxCc7 Further company coverage: SENO.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Senores Pharmaceuticals
See all newsBrief: Senores Pharmaceuticals Approves Re-Appointment Of Swapnil Jatinbhai Shah As Managing Director
Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
Brief: Senores Pharmaceuticals Says To Incorporate Units In Mexico, Canada
Brief: Senores Pharmaceuticals Ltd June-Quarter Consol Net Profit 307.2 Million Rupees
Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees